Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance
暂无分享,去创建一个
Milind Tambe | Bryan Wilder | Evan Lester | Daniel B Larremore | James A Hay | Milind Tambe | D. Larremore | M. Mina | B. Wilder | J. Burke | Michael J Mina | Roy Parker | Soraya Shehata | James M Burke | J. Hay | E. Lester | S. Shehata | R. Parker
[1] The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] A. Perelson,et al. Influenza A virus infection kinetics: quantitative data and models , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[3] J. Chan,et al. Associations of Clinical Characteristics and Antiviral Drugs with Viral RNA Clearance in Patients with COVID-19 in Guangzhou, China , 2020 .
[4] Sarah K. Helman,et al. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset , 2020, eLife.
[5] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[6] Paramveer S. Dhillon,et al. Interdependence and the cost of uncoordinated responses to COVID-19 , 2020, Proceedings of the National Academy of Sciences.
[7] D. Raoult,et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[8] Joel Hellewell,et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[9] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[10] M. M. van der Eerden,et al. Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants , 2020, medRxiv.
[11] Yang Liu,et al. Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.
[12] Lukas P. M. Kremer,et al. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples , 2020, Science Translational Medicine.
[13] M. Koopmans,et al. SARS-CoV-2 is transmitted via contact and via the air between ferrets , 2020, bioRxiv.
[14] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[15] Rochelle P. Walensky,et al. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States , 2020, JAMA network open.
[16] E. Lavezzo,et al. Suppression of COVID-19 outbreak in the municipality of Vo, Italy , 2020, medRxiv.
[17] Shahin Jabbari,et al. Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City , 2020, Proceedings of the National Academy of Sciences.
[18] S. Bhatt,et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ , 2020, Nature.
[19] Mark Jit,et al. Projecting social contact matrices in 152 countries using contact surveys and demographic data , 2017, PLoS Comput. Biol..
[20] Eric Song,et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs , 2020, medRxiv.
[21] M. Lipsitch,et al. Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study , 2020, The Lancet Infectious Diseases.
[22] Eric J Topol,et al. Prevalence of Asymptomatic SARS-CoV-2 Infection , 2020, Annals of Internal Medicine.
[23] Klasse Pj,et al. Molecular determinants of the ratio of inert to infectious virus particles. , 2015 .
[24] P. Klasse,et al. Molecular determinants of the ratio of inert to infectious virus particles. , 2015, Progress in molecular biology and translational science.
[25] Jian-ming Wang,et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China , 2020, Science China Life Sciences.
[26] J. Chan,et al. Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study , 2020, medRxiv.
[27] D. Larremore,et al. Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City , 2020, Nature Communications.
[28] Jorge X. Velasco-Hernandez,et al. In-host Modelling of COVID-19 Kinetics in Humans , 2020, medRxiv.
[29] Sarah K. Helman,et al. Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infection , 2020, medRxiv.
[30] The Murine Polyomavirus MicroRNA Locus Is Required To Promote Viruria during the Acute Phase of Infection , 2018, Journal of Virology.
[31] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[32] R. Baric,et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques , 2020, Science.
[33] Yoon-Seok Chung,et al. Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea , 2020, Journal of Korean medical science.
[34] Anne Kimball,et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.
[35] S. Bhatt,et al. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[36] Y. Xiong,et al. Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China , 2020, JAMA network open.
[37] L. Leinwand,et al. Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers , 2020, medRxiv : the preprint server for health sciences.
[38] A. Schuchat,et al. Superspreading SARS Events, Beijing, 2003 , 2004, Emerging infectious diseases.
[39] Sheng Zhang,et al. Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] Dena Goffman,et al. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.
[41] Henrik Stryhn,et al. Selection of a Cutoff Value for Real-Time Polymerase Chain Reaction Results to Fit a Diagnostic Purpose: Analytical and Epidemiologic Approaches , 2011, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.
[42] M. Kulldorff,et al. Geographic Clusters in Underimmunization and Vaccine , 2015 .
[43] G. Ebel,et al. Longitudinal Surveillance for SARS-CoV-2 RNA Among Asymptomatic Staff in Five Colorado Skilled Nursing Facilities: Epidemiologic, Virologic and Sequence Analysis , 2020 .
[44] B. Singer,et al. The implications of silent transmission for the control of COVID-19 outbreaks , 2020, Proceedings of the National Academy of Sciences.
[45] M. Cevik,et al. SARS-CoV-2, SARS-CoV-1 and MERS-CoV Viral Load Dynamics, Duration of Viral Shedding and Infectiousness: A Living Systematic Review and Meta-Analysis , 2020, SSRN Electronic Journal.
[46] Yicheng Fang,et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.
[47] Nicholas P. Tatonetti,et al. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions , 2020, bioRxiv.
[48] P. Sorger,et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques , 2020, Science.
[49] Eriko,et al. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays , 2020 .
[50] Martin Kulldorff,et al. Geographic Clusters in Underimmunization and Vaccine Refusal , 2015, Pediatrics.
[51] J. Ruijter,et al. Amplification of nonspecific products in quantitative polymerase chain reactions (qPCR) , 2017, Biomolecular detection and quantification.
[52] S. Sawyer,et al. A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround , 2020, medRxiv.
[53] Malik Peiris,et al. Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.
[54] Jean Thierry-Mieg,et al. Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions , 2020, bioRxiv.
[55] G. Ebel,et al. Longitudinal Surveillance for SARS-CoV-2 Among Staff in Six Colorado Long-Term Care Facilities: Epidemiologic, Virologic and Sequence Analysis , 2020, medRxiv.
[56] H. Tani,et al. Viral load dynamics in transmissible symptomatic patients with COVID-19 , 2020, medRxiv.
[57] S. Ruggles. Integrated Public Use Microdata Series , 2021, Encyclopedia of Gerontology and Population Aging.
[58] Hannah Fry,et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[59] Yiu Chung Lau,et al. Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.
[60] S. Alexandersen,et al. SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication , 2020, Nature Communications.
[61] Haiyan Wang,et al. Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers , 2020, Frontiers in Medicine.